

PT376 – Sherry Rais – Ketamine and Psychedelic-Assisted Therapy as Employee Benefits
14 snips Dec 6, 2022
Sherry Rais, CEO/Co-Founder of Enthea, discusses offering psychedelic therapy through employer health plans, personal anecdotes on running and cultural influences, advocating for mental health equity, expanding access to psychedelic therapy services, implementing ketamine-assisted therapy for employers, and the global deployment of psychedelic medicines.
Chapters
Transcript
Episode notes
1 2 3 4 5 6 7 8
Introduction
00:00 • 4min
Running, Chocolate, and Cultural Influences
04:24 • 9min
Journey from Anti-Drugs to Psychedelic Therapy Advocate
13:21 • 19min
Expanding Access to Psychedelic Therapy Services
32:40 • 26min
Exploring Ketamine-Assisted Therapy Implementation
58:28 • 5min
Exploring the Need for Enthia Program Globally in the Face of Healthcare Inequalities
01:03:39 • 2min
International Deployment of Psychedelic Medicines and Nomadic Living
01:05:25 • 2min
Journey from Nomadic Adventures to Investor Funding
01:07:25 • 4min